CClinicalTrials.gg
CompletedNCT07534293HIITCRECOGUpdated Apr 16, 2026

Effects of 7-Day Creatine Supplementation on Cognitive Function After High-Intensity Interval Training in Active Young Men

An interventional study of Creatine Monohydrate and Creatine Monohydrate in Creatine Supplementation and Exercise Ergogenics, sponsored by Universitas Negeri Malang. Completed at 1 site in Indonesia. Open to male participants aged 19 Years to 25 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-04-16.

Sponsored by Universitas Negeri Malang · Not applicable, Interventional, and Basic science

Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Randomized
Ages
19 Years to 25 Years
Sex
Male
01

Study summary

This study evaluates whether 7-day creatine monohydrate supplementation affects cognitive function after high-intensity interval training (HIIT) in active young men. Twenty participants were assigned to one of four groups: placebo plus exercise, placebo without exercise, creatine 0.1 g/KgBW/day plus exercise, or creatine 0.3 g/KgBW/day plus exercise. Cognitive performance was measured before and after the intervention using visual reaction time, go/no-go visual reaction time, and Trail Making Tests A and B.

Read the detailed description

This study used a controlled pretest-posttest, four-arm interventional design to examine the effects of short-term creatine monohydrate supplementation on cognitive function after high-intensity interval training (HIIT) in active young men. Twenty participants were allocated into four groups: placebo plus exercise, placebo without exercise, creatine 0.1 g/KgBW/day plus exercise, and creatine 0.3 g/KgBW/day plus exercise. The intervention lasted 7 days.

Participants in the exercise groups completed a bodyweight HIIT protocol consisting of two rounds. Round 1 used 40 seconds of work and 20 seconds of rest, and round 2 used 30 seconds of work and 15 seconds of rest, with 30 seconds of rest between rounds. The session included 14 sequential movements and was preceded by a 5-minute warm-up and followed by a 5-minute cool-down.

Cognitive performance was assessed before and after the intervention using visual reaction time (VRT), go/no-go visual reaction time (GNGVRT), and Trail Making Test Parts A and B. These measures were selected to capture processing speed, inhibitory control, attention, and executive function. The study was approved by the ethics committee of Universitas Negeri Malang, and written informed consent was obtained from all participants.

02

Conditions studied

  • Creatine Supplementation
  • Exercise Ergogenics

Keywords

  • creatine monohydrate
  • High Intensity Interval Training
  • Cognitive
  • Reaction Time
  • Executive Function
03

In context

Lead sponsor

This is the only study on the registry with Universitas Negeri Malang as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
19 Years to 25 Years
Sexes eligible
Male
Accepts healthy volunteers
Yes

Inclusion criteria

  • Male sport science students aged 19 to 25 years
  • Physically active and accustomed to high-intensity exercise
  • Healthy volunteers
  • Willing to participate and provide written informed consent
  • Willing to complete the 7-day intervention and cognitive testing procedures

Exclusion criteria

Exclusion Criteria:

  • History of cardiovascular disease
  • History of kidney disease
  • Current use of creatine supplements
  • Current use of pre-workout supplements, steroids, or diuretics
  • Any musculoskeletal, neurological, or medical condition that could interfere with exercise participation or cognitive testing
  • Refusal or inability to complete the study procedures
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
20 participants (actual)

Study arms

  • Placebo comparator
    Placebo + Exercise

    Participants received placebo supplementation using maltodextrin for 7 days and performed high-intensity interval training.

    Drug: Placebo · Behavioral: High Intensity Interval Training

  • Placebo comparator
    Placebo Without Exercise

    Participants received placebo supplementation using maltodextrin for 7 days without exercise intervention.

    Drug: Placebo

  • Experimental
    Creatine 0,1 g/KgBW/day + Exercise

    Participants received creatine monohydrate supplementation at 0,1 g/KgBW/day for 7 days and performed high-intensity interval training.

    Drug: Creatine Monohydrate · Behavioral: High Intensity Interval Training

  • Experimental
    Creatine 0,3 g/KgBW/day + Exercise

    Participants received creatine monohydrate supplementation at 0,3 g/KgBW/day for 7 days and performed high-intensity interval training.

    Drug: Creatine Monohydrate · Behavioral: High Intensity Interval Training

Interventions

  • DrugCreatine Monohydrate

    Creatine monohydrate supplementation at a dose of 0,1 g/KgBW/day for 7 days.

  • DrugCreatine Monohydrate

    Creatine monohydrate supplementation at a dose of 0,3 g/KgBW/day for 7 days.

  • DrugPlacebo

    Placebo supplementation for 7 days

  • BehavioralHigh Intensity Interval Training

    A bodyweight high-intensity interval training program performed in 2 rounds with 40 seconds work and 20 seconds rest in round 1, and 30 seconds work and 15 seconds rest in round 2, with 30 seconds rest between rounds.

06

What researchers measure

Primary outcomes

  1. Go/No-Go Visual Reaction Time False Alarm Errors

    Number of false alarm (commission) errors recorded during the Go/No-Go Visual Reaction Time test. Lower values indicate better inhibitory control.

    Time frame: Baseline and Day 7

Secondary outcomes

  1. Go/No-Go Visual Reaction Time

    Average response time for correct go trials during the Go/No-Go Visual Reaction Time test, expressed in milliseconds. Lower values indicate faster processing speed.

    Time frame: Baseline and Day 7

  2. Trail Making Test Part B Completion Time

    Trail Making Test Part B Completion Time

    Time frame: Baseline and Day 7

  3. Visual Reaction Time

    Simple visual reaction time measured in milliseconds. Lower values indicate faster processing speed.

    Time frame: Baseline and Day 7

  4. Trail Making Test Part A Completion Time

    Trail Making Test Part A Completion Time

    Time frame: Baseline and Day 7

07

Study locations

1 site
  • Laboratory Sports Science Universitas Negeri Malang
    Malang, East Java 65145, Indonesia
08

References and documents

Individual participant data

Plan to share: Undecided — The plan for sharing individual participant data has not yet been finalized.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 16, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07534293
Lead sponsor
Universitas Negeri Malang
Responsible party
Gosy Endra Vigriawan (Lecturer, Department of Sport Science,, Universitas Negeri Malang) — Principal investigator
First posted
Apr 16, 2026
Start date
Feb 7, 2026
Primary completion
Feb 14, 2026
Completion
Feb 14, 2026
Last update
Apr 16, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion